RABEPRAZOLE CH rabeprazole sodium 20mg enteric coated tablet blister pack

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

rabeprazole sodium, Quantity: 20 mg

Saatavilla:

Amneal Pharma Australia Pty Ltd

INN (Kansainvälinen yleisnimi):

Rabeprazole sodium

Lääkemuoto:

Tablet, enteric coated

Koostumus:

Excipient Ingredients: diethyl phthalate; mannitol; ethylcellulose; magnesium stearate; iron oxide yellow; povidone; sodium starch glycollate type A; hypromellose phthalate; titanium dioxide; purified talc; light magnesium oxide

Antoreitti:

Oral

Kpl paketissa:

30

Prescription tyyppi:

(S4) Prescription Only Medicine

Käyttöaiheet:

Rabeprazole is indicated for: - Treatment and prevention of relapse of gastro-oesophageal reflux disease. - Symptomatic treatment of gastro-oesophageal reflux disease. - Treatment of duodenal ulcers. - Treatment of gastric ulcers. Patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (NSAIDs) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. Rabeprazole is also indicated, in combination with clarithromycin and amoxycillin, for: - Eradication of Helicobacter pylori in patients with peptic ulcer disease or chronic gastritis. - Healing of peptic ulcers in patients with Helicobacter pylori associated ulcers.

Tuoteyhteenveto:

Visual Identification: Yellow coloured, round, biconvex, delayed release tablet, plain on both sides.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Valtuutuksen tilan:

Registered

Valtuutus päivämäärä:

2012-07-09